These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14574211)

  • 1. History of postoperative nausea and vomiting.
    Raeder J
    Int Anesthesiol Clin; 2003; 41(4):1-12. PubMed ID: 14574211
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorpromazine and chlorcyclizine in the prevention of postoperative nausea and vomiting. Acta Anaesth. Scandinav. 1958, 2, 153-162.
    Kvisselgaard N
    Acta Anaesthesiol Scand; 2007 Sep; 51(8):979-88; discussion 989-90. PubMed ID: 17697290
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT
    Kovac AL
    Drugs; 2016 Dec; 76(18):1719-1735. PubMed ID: 27988869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting.
    Loewen PS; Marra CA; Zed PJ
    Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
    Saito M; Tsukuda M
    Expert Opin Pharmacother; 2010 Apr; 11(6):1003-14. PubMed ID: 20307224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis.
    George RB; Allen TK; Habib AS
    Anesth Analg; 2009 Jul; 109(1):174-82. PubMed ID: 19535708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
    Neufeld SM; Newburn-Cook CV
    J Neurosurg Anesthesiol; 2007 Jan; 19(1):10-7. PubMed ID: 17198095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis.
    Tricco AC; Soobiah C; Blondal E; Veroniki AA; Khan PA; Vafaei A; Ivory J; Strifler L; Ashoor H; MacDonald H; Reynen E; Robson R; Ho J; Ng C; Antony J; Mrklas K; Hutton B; Hemmelgarn BR; Moher D; Straus SE
    BMC Med; 2015 Jun; 13():136. PubMed ID: 26084277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
    Hsu ES
    Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing maternal care by anesthesiologists: the role of 5-HT3 antagonists in preventing nausea and vomiting in cesarean section deliveries.
    DI Filippo A; Romagnoli S
    Minerva Anestesiol; 2024; 90(7-8):601-602. PubMed ID: 38775444
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists.
    Kovac AL
    J Clin Anesth; 2006 Jun; 18(4):304-18. PubMed ID: 16797435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol Versus 5-HT
    Singh PM; Borle A; Makkar JK; Trikha A; Fish D; Sinha A
    J Clin Pharmacol; 2018 Feb; 58(2):131-143. PubMed ID: 28914976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
    Board T; Board R
    AORN J; 2006 Jan; 83(1):209-16, 219-20. PubMed ID: 16528908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiopathology, risk factors and therapy. Postoperative Nausea and vomiting (PONV)].
    Wurglics M; Spiegl F
    Pharm Unserer Zeit; 2007; 36(5):368-72. PubMed ID: 17722164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiemetic therapy in preclinical emergency medicine - a literature review].
    Luxen J; Trentzsch H; Urban B; Prückner S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2015 Apr; 50(4):238-43. PubMed ID: 25919820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.
    Eberhart LH; Morin AM; Bothner U; Georgieff M
    Acta Anaesthesiol Scand; 2000 Nov; 44(10):1252-7. PubMed ID: 11065206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
    Ho KY; Gan TJ
    Curr Opin Anaesthesiol; 2006 Dec; 19(6):606-11. PubMed ID: 17093363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.